This medical discipline is a rapidly evolving field that combines the use of diagnostic molecular imaging with targeted radionuclide therapy for the diagnosis and treatment of cancer. This new Blended Intensive Programme (BIP) on radiotheranostics will provide participants with a comprehensive understanding of the principles and practice of radiotheranostics.

The BIP involves 4 CIVIS alliance partner universities (ULB, NKUA, TUB, AMU). Also, we have selected a number of internationally recognized academic experts in this discipline to offer students the highest scientific and pedagogical quality.

The physical mobility part of the course will take place in Brussels, between 30 June - 4 July 2025. Building upon the foundational knowledge acquired through the online courses, the physical component of the program delves deeper into the biomedical scientific principles of these radiotheranostics and practical applications of radiotheranostics will be offered. Participants will engage in interactive sessions with the instructors/ professors that reinforce their understanding and equip them with the skills to apply radiotheranostic techniques in real-world settings.

A key highlight of the face-to-face program is the opportunity to witness the practical application of radiotheranostics firsthand. Participants will embark on a guided tour of the radiopharmacy laboratory, gaining insights into the intricate processes involved in radiopharmaceutical preparation. Additionally, they will observe the treatment of a patient using radiotheranostics, gaining firsthand exposure to the clinical implementation of this innovative therapy.

Through this immersive and hands-on approach, participants will solidify their understanding of radiotheranostics and gain the confidence to apply their knowledge in their respective fields. To foster a deeper understanding and engagement with radiotheranostics, the program incorporates a range of innovative pedagogical approaches:

• problem-based learning 
• visualization of complex clinical cases 
• observing radionuclide treatment 
• radiopharmacy laboratory and preclinical research facilities visit 

The virtual component of the course will be running from 19 January to 28 March 2025: 

Module 1: Radiotheranostics Overview

• Introduction to Radiotheranostics

Module 2: Radiochemistry and Radiopharmacy 

• Basics of Radiochemistry
• Radiopharmacy Practices

Module 3: Radiobiology 

• Fundamentals of Radiobiology
• Radiobiological Principles in Therapy

Module 4: Cancer Biology 

• Introduction to Cancer Biology
• Targeted Therapies in Cancer

Module 5: Nuclear Physics and Medical Physics

• Basics of Nuclear Physics
• Principles of Medical Physics
• Dosimetry in Radiotheranostics